A retrospective observational study to determine retinal perfusion density changes on optical coherence tomography angiography and OCT thickness alterations associated with acutely increased IOP after intravitreal injections of bevacizumab or aflibercept
Latest Information Update: 20 May 2021
At a glance
- Drugs Aflibercept (Primary) ; Bevacizumab (Primary)
- Indications Diabetic retinopathy; Macular degeneration; Retinal disorders; Retinal neovascularisation; Retinal vein occlusion
- Focus Therapeutic Use
- 20 May 2021 New trial record